28
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Aberrant Expression of the NF-κB and IκB Proteins in B Cells from Viable Motheaten Mice

, , , &
Pages 115-128 | Received 06 Nov 1998, Accepted 03 Feb 1999, Published online: 07 Jul 2009
 

Abstract

In viable motheaten mice, a mutation in the gene encoding the phosphatase, SHP1, causes severe immunodeficiency and autoimmunity. A defective phosphatase may result in modified phosphorylation of proteins involved in gene regulation. Since the NFκB/IκB proteins are regulated through phosphorylation, we wished to understand if the expression of these proteins was altered by the SHP1 defect. Splenic B cells from viable motheaten mice were isolated and assessed for purity by flow cytometry. Levels of each protein in isolated B cells were examined by Western blot analyses. Measurement of RNA levels for each protein was assessed by semi-quantitative RT-PCR. Western blots revealed that, in mev whole cell lysates, there were reduced levels of Re1A and Re1B proteins and increased levels of p50 and c-Re1. Furthermore, we analyzed the protein levels of IκBU and found that, in mev, this inhibitor was significantly reduced, while the level of another member of the IκB family, IκBβ, was not. To determine if these findings in mev were secondary to the autoimmune process, we evaluated NF-KB/IKB expression in the BXSB murine model of autoimmunity. Unlike mev, B cells from BXSB/Yaa mice had NF-κB complexes composed of the Re1A submit, and IκBα was readily detected. In addition, RNA for the Re1A and IκBα proteins in mev and control littermates was detected by RT-PCR, indicating that the reduced amounts of these proteins was not exclusively due to transcriptional defects. We conclude that the differences in NF-κB/IκB proteins that we have described in mev are likely a consequences of the SHP1 defect and could contribute to the clinical disorder that characterizes mev mice.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.